About: randomized

Head noun: randomized

Same concepts
http://dbpedia.org/resource/Randomness

Broader concepts

label	provenance	confidence
further study	isap:473566544	0.440846
clinical trial	isap:474114110	0.420976
trial	isap:474114111	0.375726
research method	isap:256534401	0.302231
study	isap:473566540	0.228094
term	isap:504180150	0.212294
analysis	isap:282920802	0.167250
method	isap:256534402	0.127174
report	isap:254744600	0.120454
datum	isap:476428618	0.095454

Narrower concepts

label	provenance	confidence
methods the current study	isap:239327538	0.561770
phase 1b clinical trial	isap:265287881	0.555387
phase 2a clinical trial	isap:265240459	0.553642
folic acid cardiovascular study	isap:259941777	0.513118
prostate cancer prevention trial	isap:260250991	0.510549
physicians health study ii	isap:265378789	0.503070
physicians health study	isap:259941756	0.485927
study	isap:259941739	0.484760
detailed description study	isap:259941745	0.484622
pilot study	isap:259941741	0.479821
primary study design	isap:18225218	0.473580
first clinical trial	isap:260251005	0.470918
clinical trial	isap:260250987	0.460468
partners prep study	isap:259941758	0.459008
phase iib trial	isap:260250989	0.455686
australian study	isap:259941819	0.454362
study designthis	isap:399410011	0.453881
phase 1b trial	isap:260250993	0.452699
phase 2a study	isap:259941759	0.452144
phase 2a trial	isap:260250998	0.448381
pivotal clinical trial	isap:260251001	0.447301
methods study	isap:259941743	0.447060
phase iib study	isap:259941767	0.446631
present study	isap:259941740	0.446529
empower study	isap:259941766	0.445725
recent study	isap:259941763	0.445317
phase 2b study	isap:259941764	0.445272
study design	isap:18225209	0.445021
methodsthis study	isap:259941795	0.442525
current study	isap:259941751	0.442134
champion trial	isap:260251031	0.440364
phase iium trial	isap:260251011	0.440019
phase iib study ap	isap:265282648	0.439740
health study	isap:259941783	0.439734
6-month study	isap:259941827	0.439724
study 06ccl3-001	isap:400005628	0.438450
study cou-aa-302	isap:399521243	0.437830
mivi ii dme trial	isap:260251025	0.437387
freedom study	isap:259941803	0.435517
design study	isap:259941762	0.435270
first trial	isap:260251003	0.434906
design trial	isap:260251004	0.434372
second trial	isap:260250988	0.431557
first study	isap:259941750	0.430008
epic trial	isap:260251012	0.429700
clinical study	isap:259941744	0.427418
globe study	isap:259941820	0.425898
more trial	isap:260251030	0.425290
study design the study	isap:259941765	0.423366
predimed study	isap:259941752	0.419281
trial design	isap:18225212	0.416895
study ai424-138	isap:43059686	0.414191
phs ii	isap:265378790	0.411110
reveal trial	isap:260251019	0.410232
pact trial	isap:260250999	0.409664
part c	isap:328374060	0.407663
part b	isap:328112809	0.406987
start study	isap:259941760	0.403452
study design study	isap:259941761	0.398975
sample size	isap:190650946	0.397545
anchor trial	isap:260250990	0.396782
new study	isap:259941821	0.393378
part a	isap:328089082	0.384566
new england journal	isap:245051855	0.382950
study study	isap:259941771	0.380281
radical study	isap:259941808	0.378141
rns system	isap:17891694	0.358145
phase 3 prevail trial	isap:258592560	0.333620
phase 3 affirm trial	isap:258592566	0.331108
phase 2 clinical trial	isap:258592549	0.328749
phase 1 clinical trial	isap:258592559	0.327892
phase 3 clinical trial	isap:258592558	0.326129
part of the study	isap:189298362	0.323640
design the study	isap:18225211	0.322225
participant the physicians health	isap:313124498	0.320194
phase ii clinical trial	isap:258592561	0.319731
phase ii trial	isap:258592554	0.318747
phase 2 trial	isap:258592546	0.317586
kinect 2 study	isap:20908226	0.316884
method the present study	isap:19888007	0.315814
phase ii study	isap:258592548	0.315438
phase iii trial	isap:258592550	0.314281
phase 2b trial	isap:258592568	0.312975
phase 3 trial	isap:258592555	0.312239
aids clinical trials group	isap:189693189	0.312223
phase iii study	isap:258592551	0.311433
phase 1 study	isap:258592552	0.308970
phase 3 study	isap:258592547	0.308761
trial	isap:260250986	0.306580
study 202	isap:259941774	0.305675
july 2005	isap:189172611	0.305069
study 888	isap:259941800	0.305069
phase 1 trial	isap:258592556	0.305038
af-timus 48	isap:180030205	0.305029
study 863	isap:259941781	0.302653
study 011	isap:259941784	0.302653
nrti study ai424-045	isap:43901725	0.298160
phase of study	isap:258592574	0.295650
metastatic patient	isap:242991078	0.294517
stage 2	isap:260506835	0.294380
part 2	isap:189298361	0.293562
phase 2	isap:258592557	0.292980
design of study	isap:18225217	0.292891
phase 2 study	isap:258592545	0.292347
part 1	isap:189298360	0.291174
study 102	isap:259941804	0.288042
study 903	isap:259941787	0.285842
hptn 039	isap:190668852	0.284288
star 3	isap:189962833	0.280884
transcatheter aortic valve implantation	isap:29273084	0.277237
spirit iii	isap:20354731	0.275760
patient	isap:242991076	0.271605
investigation	isap:29155849	0.266134
phase iii clinical trial	isap:258592571	0.266090
aristotle	isap:42832449	0.252851
paradigm-hf	isap:312507438	0.252643
designthis	isap:399410012	0.235587
algorithm	isap:43344118	0.234266
methodology	isap:313228024	0.233327
exception	isap:42938757	0.230814
research	isap:180060024	0.226846
comet-1	isap:242774793	0.224107
however	isap:243425764	0.223994
woman	isap:259840737	0.222026
project	isap:243138135	0.220541
wafacs	isap:20670442	0.218197
canada	isap:17751069	0.217975
vista-16	isap:182541539	0.217017
zodiac	isap:20728939	0.216185
areds2	isap:19733294	0.215708
aspire	isap:18317200	0.215306
agenda	isap:17896853	0.211889
impact	isap:19308609	0.211318
benefit-al	isap:399324222	0.210565
start	isap:258049604	0.210317
adapt	isap:259384456	0.210037
spartan	isap:243623703	0.209920
today	isap:258285830	0.209169
promise	isap:244702625	0.208830
paper	isap:258399156	0.208463
test	isap:191651286	0.205529
work	isap:191530425	0.205423
zest	isap:190933417	0.205423
bridge	isap:20474084	0.204187
select	isap:20148898	0.204133
vent	isap:191163587	0.204090
first	isap:261034894	0.201784
methods	isap:242861607	0.201428
benefit	isap:243505026	0.200237
saturn	isap:20716365	0.200127
design	isap:18225210	0.200111
iat	isap:239236884	0.199670
briefly	isap:242478848	0.198413
article	isap:243852667	0.197275
zeal	isap:188598617	0.197250
company	isap:244230678	0.197038
ph	isap:265168947	0.195273
iii	isap:238515641	0.194157
wh	isap:265235881	0.193926
camp	isap:188365145	0.192620
bravo	isap:260322985	0.191202
material	isap:180785769	0.190585
information	isap:313127665	0.188333
materials	isap:42666793	0.187847
citad	isap:257922056	0.187784
s	isap:328220076	0.185202
efficacy	isap:181982709	0.182626
spark	isap:260549888	0.180003
method	isap:19888005	0.176313
ppt	isap:237573109	0.175241
phase	isap:258592567	0.173162
setting	isap:243827944	0.168567
about	isap:261309905	0.167942
y	isap:328050909	0.163374
none	isap:190168833	0.146836
the	isap:239327537	0.138294
safety	isap:20321257	0.134310